Advertisement

Annals of Surgical Oncology

, Volume 21, Issue 13, pp 4330–4335 | Cite as

Flow Cytometric Evaluation of the Safety of Intraoperative Salvaged Blood Filtered with Leucocyte Depletion Filter in Spine Tumour Surgery

  • Naresh Kumar
  • Raymond Lam
  • Aye Sandar Zaw
  • Rishi Malhotra
  • Jonathan Tan
  • Gamaliel Tan
  • Tony Setiobudi
Neuro-Oncology

Abstract

Background

Intraoperative cell salvage (IOCS) has not been widely adopted in oncological surgery due to the hypothetical concern of reinfusion of malignant cells. We evaluated the feasibility of IOCS in combination with leucocyte depletion filter (LDF) in metastatic spine tumour surgery (MSTS).

Methods

Patients with known primary epithelial tumour, operated for metastatic spinal disease, were recruited. Blood samples were collected at five different stages during surgery: 2 stages from patient vein during induction and at the time of maximum tumour manipulation, 3 stages from the operative blood prior to IOCS processing, after IOCS processing, and after IOCS–LDF processing. Of the samples taken at each stage, 5 ml were analyzed for tumour cells using flow cytometry.

Results

Of 12 patients recruited, only 11 could be finally analyzed. Flow cytometry analysis of their samples showed that 8 of 11 patients had tumour cells in the unfiltered salvaged blood. In filtered salvaged blood, the tumour cell count was zero in the majority of samples (8/11 patients), whereas three patients’ samples had a few tumour cells. The mean difference between the tumour cell quantity in the samples from the patient vein and filtered salvaged blood was significant.

Conclusions

IOCS–LDF was shown to be effective in removing tumour cells from the blood salvaged during MSTS. If there were any tumour cells found, the quantity was significantly less than that in the patient’s circulation. The results of this study reiterates the conclusions of our previous published work where we showed that IOCS–LDF treated blood in MSTS is safe for transfusion.

Keywords

Circulate Tumour Cell Allogeneic Blood Viable Tumour Cell Epidural Abscess Allogeneic Blood Transfusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

The manpower of this research was supported by National Medical Research Council, Singapore. We were awarded the grant in November 2010 to conduct a prospective study (Grant number: NMRC/NIG/1055/2011; Value of award: SGD 200,000.00; DSRB/IRB reference: 2011/00350). The laboratory procedure and consumables were supported by 2014 AOSpine East Asia Research Award. The authors thank A/Prof Gabriel Liu, A/Prof Joseph Thambiah, and Prof Hee Kit Wong for contributing their cases to the study and the Anaesthesia Unit (AU) Nurses at the NUHS and Alexandra Hospital (AH) Singapore for supporting the study by managing the IOCS machine and the LDF system.

Conflict of interest

None.

References

  1. 1.
    Chen Y, Tai BC, Nayak D, et al. Blood loss in spinal tumour surgery and surgery for metastatic spinal disease: a meta-analysis. Bone Joint J. 2013;95-B:683–8.Google Scholar
  2. 2.
    Blajchman MA, Bordin JO. The tumor growth-promoting effect of allogeneic blood transfusions. Immunol Invest. 1995;24(1–2):311–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Blumberg N. Allogeneic transfusion and infection: economic and clinical implications. Semin Hematol. 1997;34(3 Suppl 2):34–40.PubMedGoogle Scholar
  4. 4.
    Kumar N, Ahmed Q, Lee VK, et al. Can there be a place for intraoperative salvaged blood in spine tumor surgery? Ann Surg Oncol. Feb 25 2014.Google Scholar
  5. 5.
    Park SY, Choi GS, Park JS, Kim HJ, Ryuk JP, Choi WH. Influence of surgical manipulation and surgical modality on the molecular detection of circulating tumor cells from colorectal cancer. J Korean Surg Soc. 2012;82(6):356–64.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Yamaguchi K, Takagi Y, Aoki S, Futamura M, Saji S. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg. 2000;232(1):58–65.PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Miller GV, Ramsden CW, Primrose JN. Autologous transfusion: an alternative to transfusion with banked blood during surgery for cancer. Br J Surg. 1991;78(6):713–5.PubMedCrossRefGoogle Scholar
  8. 8.
    Martin RC, Wellhausen SR, Moehle DA, Martin AW, McMasters KM. Evaluation of intraoperative autotransfusion filtration for hepatectomy and pancreatectomy. Ann Surg Oncol. 2005;12(12):1017–24.PubMedCrossRefGoogle Scholar
  9. 9.
    Catling S, Williams S, Freites O, Rees M, Davies C, Hopkins L. Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood. Anaesthesia. 2008;63(12):1332–8.PubMedCrossRefGoogle Scholar
  10. 10.
    McKenna SJ. Autologous blood transfusions. Council on Scientific Affairs. J Am Med Assoc. 1986;256:2378–80.Google Scholar
  11. 11.
    Waters JH, Yazer M, Chen YF, Kloke J. Blood salvage and cancer surgery: a meta-analysis of available studies. Transfusion. Feb 10 2012.Google Scholar
  12. 12.
    Klimberg I, Sirois R, Wajsman Z, Baker J. Intraoperative autotransfusion in urologic oncology. Arch Surg. 1986;121(11):1326–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Connor JP, Morris PC, Alagoz T, Anderson B, Bottles K, Buller RE. Intraoperative autologous blood collection and autotransfusion in the surgical management of early cancers of the uterine cervix. Obstet Gynecol. 1995;86(3):373–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Perseghin P, Vigano M, Rocco G, Della Pona C, Buscemi A, Rizzi A. Effectiveness of leukocyte filters in reducing tumor cell contamination after intraoperative blood salvage in lung cancer patients. Vox Sang. 1997;72(4):221–4.PubMedCrossRefGoogle Scholar
  15. 15.
    Muller M, Kuhn DF, Hinrichs B, et al. [Is the elimination of osteosarcoma cells with intraoperative “mesh autotransfusion” and leukocyte depletion filters possible?]. Anaesthesist. 1996;45(9):834–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Kongsgaard UE, Wang MY, Kvalheim G. Leucocyte depletion filter removes cancer cells in human blood. Acta Anaesthesiol Scand. 1996;40(1):118–20.PubMedCrossRefGoogle Scholar
  17. 17.
    Edelman MJ, Potter P, Mahaffey KG, Frink R, Leidich RB. The potential for reintroduction of tumor cells during intraoperative blood salvage: reduction of risk with use of the RC-400 leukocyte depletion filter. Urology. 1996;47(2):179–81.PubMedCrossRefGoogle Scholar
  18. 18.
    Mirhashemi R, Averette HE, Deepika K, et al. The impact of intraoperative autologous blood transfusion during type III radical hysterectomy for early-stage cervical cancer. Am J Obstet Gynecol. 1999;181(6):1310–5; discussion 1315–6.Google Scholar
  19. 19.
    Foltys D, Zimmermann T, Heise M, et al. Liver transplantation for hepatocellular carcinoma–is there a risk of recurrence caused by intraoperative blood salvage autotransfusion? Eur Surg Res. 2011;47(3):182–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Kim JM, Kim GS, Joh JW, et al. Long-term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter. Transpl Int. 2012;26(1):84–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Fujimoto J, Okamoto E, Yamanaka N, et al. Efficacy of autotransfusion in hepatectomy for hepatocellular carcinoma. Arch Surg. 1993;128(9):1065–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Bower MR, Ellis SF, Scoggins CR, McMasters KM, Martin RC. Phase II comparison study of intraoperative autotransfusion for major oncologic procedures. Ann Surg Oncol. 2011;18(1):166–173.PubMedCrossRefGoogle Scholar
  23. 23.
    Gorin MA, Eldefrawy A, Manoharan M, Soloway MS. Oncologic outcomes following radical prostatectomy with intraoperative cell salvage. World J Urol. 2012;30(3):379–383.PubMedCrossRefGoogle Scholar
  24. 24.
    Gray CL, Amling CL, Polston GR, Powell CR, Kane CJ. Intraoperative cell salvage in radical retropubic prostatectomy. Urology. 2001;58(5):740–745.PubMedCrossRefGoogle Scholar
  25. 25.
    Nieder AM, Carmack AJ, Sved PD, Kim SS, Manoharan M, Soloway MS. Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate. Urology. 2005;65(4):730–4.PubMedCrossRefGoogle Scholar
  26. 26.
    Nieder AM, Manoharan M, Yang Y, Soloway MS. Intraoperative cell salvage during radical cystectomy does not affect long-term survival. Urology. 2007;69(5):881–4.PubMedCrossRefGoogle Scholar
  27. 27.
    Stoffel JT, Topjian L, Libertino JA. Analysis of peripheral blood for prostate cells after autologous transfusion given during radical prostatectomy. BJU Int. 2005;96(3):313–5.PubMedCrossRefGoogle Scholar
  28. 28.
    Hristozova T, Konschak R, Budach V, Tinhofer I. A simple multicolor flow cytometry protocol for detection and molecular characterization of circulating tumor cells in epithelial cancers. Cytom A. 2012;81(6):489–95.PubMedCrossRefGoogle Scholar
  29. 29.
    Poli M, Camargo A, Villa L, Moura R, Colella R, Deheinzelin D. Intraoperative autologous blood recovery in prostate cancer surgery: in vivo validation using a tumour marker. Vox Sang. 2008;95(4):308–12.PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2014

Authors and Affiliations

  • Naresh Kumar
    • 1
  • Raymond Lam
    • 1
  • Aye Sandar Zaw
    • 1
  • Rishi Malhotra
    • 1
  • Jonathan Tan
    • 1
  • Gamaliel Tan
    • 2
  • Tony Setiobudi
    • 2
  1. 1.Department of Orthopaedic Surgery, NUHS Tower Block, Level 11National University Health SystemSingaporeSingapore
  2. 2.Department of Orthopaedic SurgeryAlexandra HospitalSingaporeSingapore

Personalised recommendations